|
ZNF350 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21579998793686E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84390000046442E-07 |
| Normal-vs-Stage2 |
2.564300E-04 |
| Normal-vs-Stage3 |
2.63939999856078E-08 |
| Normal-vs-Stage4 |
1.54059999979417E-07 |
| Stage1-vs-Stage2 |
8.857400E-01 |
| Stage1-vs-Stage3 |
4.449700E-02 |
| Stage1-vs-Stage4 |
3.145900E-02 |
| Stage2-vs-Stage3 |
2.335200E-01 |
| Stage2-vs-Stage4 |
1.186420E-01 |
| Stage3-vs-Stage4 |
5.952600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05170003209076E-09 |
| Normal-vs-AfricanAmerican |
3.356300E-02 |
| Normal-vs-Asian |
9.79119999999778E-05 |
| Caucasian-vs-AfricanAmerican |
1.321630E-01 |
| Caucasian-vs-Asian |
4.834800E-01 |
| AfricanAmerican-vs-Asian |
3.588200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03829999999572E-05 |
| Normal-vs-Female |
7.87739984353664E-10 |
| Male-vs-Female |
1.707550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.57110000143757E-08 |
| Normal-vs-Age(41-60Yrs) |
6.1542999996167E-07 |
| Normal-vs-Age(61-80Yrs) |
1.26800000055383E-07 |
| Normal-vs-Age(81-100Yrs) |
8.915400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.845600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.804200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.739400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.035000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.563800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.897200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.618100E-03 |
| Classical-VS-Follicular |
9.688000E-01 |
| Classical-VS-Other |
5.186800E-01 |
| Classical-VS-Normal |
1.61544999999208E-05 |
| Tall-VS-Follicular |
3.737600E-03 |
| Tall-VS-Other |
1.298380E-01 |
| Tall-VS-Normal |
2.96540003663637E-09 |
| Follicular-VS-Other |
4.498400E-01 |
| Follicular-VS-Normal |
1.192950E-04 |
| Other-VS-Normal |
3.094000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00629999999491E-06 |
| Normal-vs-N1 |
1.34519999583915E-08 |
| N0-vs-N1 |
7.684600E-03 |
|
|
